|
| Thursday, November 24, 2022 |
|
|
医思健康公布2022/23年度中期业绩 医疗服务业务推动收入同比增长31.1% |
| 香港最大非医院医疗服务机构* ── 医思健康（“公司”，连同附属公司，总称“集团”；香港联交所股份编号：2138）公布截至2022年9月30日止六个月（“期内”）未经审核之中期业绩。 more info >> |
|
|
醫思健康公佈2022/23年度中期業績 醫療服務業務推動收入同比增長31.1% |
| 香港最大非醫院醫療服務機構* ── 醫思健康（「公司」，連同附屬公司，總稱「集團」；香港聯交所股份編號：2138）公佈截至2022年9月30日止六個月（「期內」）未經審核之中期業績。 more info >> |
|
|
EC Healthcare Announces FY2022/23 Interim Results, Revenue Increased 31.1% YoY Mainly Driven by Medical Services |
| EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong, announces today its unaudited interim results for the six months ended 30 September 2022 (the "Period"). more info >> |
|
| Monday, October 17, 2022 |
|
|
医思健康料23上半财年销售额创新高至不少于18亿港元 按年升不少于17% |
| 香港最大非医院医疗服务机构* ── 医思健康（「公司」，连同附属公司，总称「集团」；香港联交所股份编号：2138）欣然宣布，集团预计截至2022年4月至9月（「期内」）之销售额创新高。 more info >> |
|
|
醫思健康料23上半財年銷售額創新高至不少於18億港元 按年升不少於17% |
| 香港最大非醫院醫療服務機構* ── 醫思健康（「公司」，連同附屬公司，總稱「集團」；香港聯交所股份編號：2138）欣然宣佈，集團預計截至2022年4月至9月（「期內」）之銷售額創新高。 more info >> |
|
|
EC Healthcare expects a record-high semi-annual sales volume in first half of FY23 of no less than HK$1.8 billion, Represents no less than 17% Y-o-Y increase |
EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group expects to achieve a record-high semi-annual sales volume from April to September 2022 (the "Reporting Period").
more info >> |
|
| Monday, October 3, 2022 |
|
|
医思健康收购香港连锁多专科医疗中心 |
| 香港最大非医院医疗服务机构* ── 医思健康（「公司」，连同附属公司，总称「集团」；香港联交所股份编号：2138）欣然宣布与卖方订立协议，收购Pioneer Evolution Limited（「目标公司」）60%已发行股本，总代价将以现金支付，总计3,640万港元。 more info >> |
|
|
醫思健康收購香港連鎖多專科醫療中心 |
| 香港最大非醫院醫療服務機構* ── 醫思健康（「公司」，連同附屬公司，總稱「集團」；香港聯交所股份編號：2138）欣然宣佈與賣方訂立協議，收購Pioneer Evolution Limited（「目標公司」）60%已發行股本，總代價將以現金支付，總計3,640萬港元。 more info >> |
|
|
EC Healthcare Acquires Multi-Disciplinary Healthcare Services Chain in Hong Kong |
| EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group and the Seller enters into a sale and purchase agreement to acquire 60% of the issued share capital of Pioneer Evolution Limited (the "Target Company") for a total consideration of HK$36.4 million in cash. more info >> |
|
| Friday, September 9, 2022 |
|
|
医思健康主席邓志辉再度增持公司股份 对集团业务未来发展保持坚定不移的信心 |
| 香港最大非医院医疗服务机构* ── 医思健康（「公司」，连同附属公司，总称「集团」；香港联交所股份编号：2138）欣然宣布，集团主席、行政总裁及执行董事邓志辉先生（「邓先生」）于2022年 9月7日再度于公开市场新增购入170,000股，涉资约85.48万港元，每股股份平均价格为5.0282港元。 more info >> |
|
|
|
|
